Facebook Linkedin Twitter
Inside Precision Medicine Merck Inks $1B Synthetic Biology Deal with Pearl

Johnson & Johnson

DNA Molecular Structure
News & Features

Merck Inks $1B Synthetic Biology Deal with Pearl

0
Antibody drug conjugated with cytotoxic payload. Synthetic Biology
News & Features

Johnson & Johnson to Acquire Clinical-Stage Antibody Drug Conjugate Company Ambrx for $2 Billion

0
Illustration of several SARS-CoV-2 virus particles in blue on a red background
Coronavirus

COVID Vaccine Booster via Inhaler Ups Protection in Monkeys

0
Artificial intelligence DNA
News & Features

“Ground-Breaking” Release of World’s Largest Whole Genome Resource

0
Cancer Gene
Molecular Dx

Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching

0
3D rendering representing interaction between brain neurons
News & Features

Neurological Precision Therapy Company Rapport Therapeutics Launches with $100 Million Series A

0
Different family types seamless pattern
Molecular Dx

U.K.’s Our Future Health Aims to Transform Disease Prevention, Detection, Treatment

0
Portrait of doctor in emergency care unit of a hospital holding bag valve mask
Coronavirus

Vaccinated Cancer Patients with Breakthrough COVID-19 Infections Have High Death Rates

0
Capsule with DNA inside
News & Features

Neurodegenerative Gene Therapy Biotech AviadoBio Exits Stealth Mode With $80M Series A

0
Blue DNA double helix on top of a print out of genetic sequence letters (black on a white background) to indicate genome sequencing carried out as part of the Estonian Biobank precision medicine project.
Informatics

Genomic Data From 200,000 UK Biobank Participants Available to Researchers

0
123Page 1 of 3

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine